関連する実験動画
Updated: Jan 8, 2026

11:40
Quantitative Autonomic Testing
Published on: July 19, 2011
58.4K
自律神経障害の治療に関するアップデート
Abdulmunaim M Eid1, Gabriel E Vázquez-Vélez1, Beatriz Maliszewski1
1Department of Neurology, Washington University, School of Medicine, 660 S. Euclid Ave, St. Louis, MO, USA.
Current treatment options in neurology
|December 17, 2025
まとめ
自律神経障害は、起立性低血圧や胃不全麻痺などの症状を引き起こします。このレビューでは、自律神経機能不全の症状を管理するために、神経調節デバイスや新薬を含む、確立された治療法と新たな治療法をカバーしています。
科学分野:
- 神経学
- 自律神経系研究
- 臨床治療学
背景:
- 自律神経障害または自律神経機能不全は、身体のホメオスタシスを破壊し、多様な症状につながります。
- 自律神経機能不全の原因は、神経変性、自己免疫疾患、薬の副作用など様々です。
- 一般的な原因に対する疾患修飾治療は限られていますが、症状管理は非常に重要です。
研究 の 目的:
- 自律神経機能不全の管理のための確立された最近の治療戦略をレビューすること。
- 自律神経障害の管理に取り組むための臨床スキーマを提供すること。
- 新しい神経調節デバイスと薬理学的薬剤を強調すること。
主な方法:
- 自律神経機能不全の確立されたおよび新たな治療戦略のレビュー。
- 一般的な臨床問題と段階的な管理アプローチに焦点を当てる。
- 非薬理学的、薬理学的、神経調節的治療の統合。
主要な成果:
- 神経調節デバイスは、起立性低血圧、排尿障害、性機能障害、便秘、胃不全麻痺に有望です。
- ドロキシドパ、β-3アドレナリン作動薬、プルカロプリド、エロビキシバット、リナクロチドなどの新しい薬は、有効性と忍容性の向上を提供します。
- 複数の戦略を統合した段階的なアプローチは、一般的な自律神経機能不全の症状の管理に役立ちます。
結論:
- 自律神経機能不全の効果的な管理は、治療戦略の組み合わせに依存します。
- 新たな神経調節および薬理学的選択肢は、治療の可能性を広げます。
- 患者ケアを最適化するための構造化された臨床アプローチが不可欠です。
関連する概念動画
Disorders of the Autonomic Nervous System
1.4K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.4K
Drugs Acting on Autonomic Ganglia: Blockers
1.6K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.6K
Autonomic Nervous System
11.9K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
11.9K
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K

